Effect of phosphorylation of MAPK and Stat3 and expression of c-fos and c-jun proteins on hepatocarcinogenesis and their clinical significance-Reference-Cited by-同舟云学术

Effect of phosphorylation of MAPK and Stat3 and expression of c-fos and c-jun proteins on hepatocarcinogenesis and their clinical significance

Published:2001 Issue:1 Volume:7 Page:33
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:en
Short-container-title:WJG

Author:

Feng De Yun

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference27 articles.

1. Activation of mitogen-activated protein kinases/extracellular signal-regulated kinases in human hepatocellular carcinoma

2. Increased MAPK Expression and Activity in Primary Human Hepatocellular Carcinoma

3. Gu SQ, Liang YY, Fan LR, Li BY, Wang DS. Co-regulative effects of the cAMP/PKA and DAG/PKC signal pathways on human gas-tric cancer cells during differentiation induced by traditional Chi-nese medicines. China Natl J New Gastroen terol 1997;3:50-53.

4. Transcriptional Regulation by Extracellular signals: Mechanisms and Specificity

5. Dual Signaling Role of the Protein Tyrosine Phosphatase SHP-2 in Regulating Expression of Acute-Phase Plasma Proteins by Interleukin-6 Cytokine Receptors in Hepatic Cells

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding Gene Involvement in Hepatocellular Carcinoma: Implications for Gene Therapy and Personalized Medicine;Pharmacogenomics and Personalized Medicine;2024-05

2. Targeting FOS attenuates malignant phenotypes of breast cancer: Evidence from in silico and in vitro studies;Journal of Biochemical and Molecular Toxicology;2023-04-04

3. Ozonated Water Inhibits Hepatocellular Carcinoma Invasion and Metastasis by Regulating the HMGB1/NF-κB/STAT3 Signaling Pathway;Journal of Hepatocellular Carcinoma;2023-02

4. Expression of p-STAT3 and c-Myc correlates with P2-HNF4α expression in nonalcoholic fatty liver disease (NAFLD);Oncotarget;2022-12-06

5. Combination treatment with sorafenib and wh‑4 additively suppresses the proliferation of liver cancer cells;Experimental and Therapeutic Medicine;2022-01-20